208 related articles for article (PubMed ID: 28676212)
1. Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry.
Dickhoff C; Dahele M; Smit EF; Paul MA; Senan S; Hartemink KJ; Damhuis RA
Lung Cancer; 2017 Aug; 110():14-18. PubMed ID: 28676212
[TBL] [Abstract][Full Text] [Related]
2. Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013.
Dickhoff C; Dahele M; de Langen AJ; Paul MA; Smit EF; Senan S; Hartemink KJ; Damhuis RA
J Thorac Oncol; 2016 Apr; 11(4):566-72. PubMed ID: 26773741
[TBL] [Abstract][Full Text] [Related]
3. Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.
Driessen EJ; Aarts MJ; Bootsma GP; van Loon JG; Janssen-Heijnen ML
Lung Cancer; 2017 Jun; 108():198-204. PubMed ID: 28625635
[TBL] [Abstract][Full Text] [Related]
4. Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis.
Guo M; Li B; Yu Y; Wang S; Xu Y; Sun X; Wang L; Yu J
Cancer Med; 2019 May; 8(5):2587-2598. PubMed ID: 30945441
[TBL] [Abstract][Full Text] [Related]
5. Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.
Driessen EJM; Schulkes KJG; Dingemans AC; van Loon JGM; Hamaker ME; Aarts MJ; Janssen-Heijnen MLG
Lung Cancer; 2018 Feb; 116():55-61. PubMed ID: 29413051
[TBL] [Abstract][Full Text] [Related]
6. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
7. GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer.
Flentje M; Huber RM; Engel-Riedel W; Andreas S; Kollmeier J; Staar S; Dickgreber N; Vaissiere N; De Almeida C; Edlich B; Fietkau R
Strahlenther Onkol; 2016 Apr; 192(4):216-22. PubMed ID: 26809652
[TBL] [Abstract][Full Text] [Related]
8. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
[TBL] [Abstract][Full Text] [Related]
9. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
10. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
11. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
12. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
13. Application of the new 8th TNM staging system for non-small cell lung cancer: treated with curative concurrent chemoradiotherapy.
Choi HS; Jeong BK; Jeong H; Lee YH; Ha IB; Song JH; Kang KM
Radiat Oncol; 2017 Jul; 12(1):122. PubMed ID: 28732516
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer.
Sher DJ; Fidler MJ; Liptay MJ; Koshy M
Lung Cancer; 2015 Jun; 88(3):267-74. PubMed ID: 25862147
[TBL] [Abstract][Full Text] [Related]
15. Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience.
Zemanova M; Pirker R; Petruzelka L; Zbozínkova Z; Jovanovic D; Rajer M; Bogos K; Purkalne G; Ceriman V; Chaudhary S; Richter I; Kufa J; Jakubikova L; Zemaitis M; Cernovska M; Koubkova L; Vilasova Z; Dieckmann K; Farkas A; Spasic J; Fröhlich K; Tiefenbacher A; Hollosi V; Kultan J; Kolarová I; Votruba J
Radiol Oncol; 2020 May; 54(2):209-220. PubMed ID: 32463394
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and Radiation Versus Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC.
Qin A; Lusk E; Daignault-Newton S; Schneider BJ
Clin Lung Cancer; 2019 Jul; 20(4):e495-e503. PubMed ID: 31088760
[TBL] [Abstract][Full Text] [Related]
17. Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function.
Dickhoff C; Hartemink KJ; van de Ven PM; van Reij EJ; Senan S; Paul MA; Smit EF; Dahele M
Lung Cancer; 2014 Aug; 85(2):218-23. PubMed ID: 24976333
[TBL] [Abstract][Full Text] [Related]
18. Patterns of care for non-small cell lung cancer patients in Belgium: A population-based study.
Verleye L; De Gendt C; Vrijens F; Schillemans V; Camberlin C; Silversmit G; Stordeur S; Van Eycken E; Dubois C; Robays J; Wauters I; Van Meerbeeck JP
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28833865
[TBL] [Abstract][Full Text] [Related]
19. Failure patterns of combined modality treatment in lung cancer: the impact of staging.
Hoekstra CJ; Rijna H; Smit EF; Van Mourik JC; Postmus PE; Lammertsma AA; Hoekstra OS
Neth J Med; 2002 Mar; 60(1):17-21. PubMed ID: 12074038
[TBL] [Abstract][Full Text] [Related]
20. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
